Moors & Cabot’s Corteva CTVA Stock Holding History

Moors & Cabot’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-500	Closed	-$2K	–	864
2022 Q3	$2K	Buy	+500	New	+$29.1K	﹤0.01%	815

Other funds holding CTVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Moors & Cabot's CTVA Position: Q1 2026 in Review

Moors & Cabot reduced its Corteva (CTVA) stake by 1.5% in Q1 2026, selling an estimated $37.2K and leaving 33,399 shares worth $2.8M. The position accounts for 0.12% of the portfolio, ranked #164.

Moors & Cabot first reported a position in CTVA in Q2 2019 and has held it in 28 quarters since. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

Moors & Cabot held 33,399 shares of Corteva worth $2.8M as of Q1 2026.
Moors & Cabot sold 494 Corteva shares in Q1 2026, an estimated $37.2K.
Corteva made up 0.12% of Moors & Cabot's portfolio in Q1 2026, its #164 holding.
Moors & Cabot first reported a position in Corteva in Q2 2019 and has held it in 28 quarters since.
1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.